铂耐药卵巢癌患者巴替拉塞与杜瓦单抗联合用药的 1b 期研究

{"title":"铂耐药卵巢癌患者巴替拉塞与杜瓦单抗联合用药的 1b 期研究","authors":"A. Knisely, Emily Hinchcliff, Elisabeth Gardiner, Reshma A. Rangwala, Kathryn Lito, B. Fellman, Ying Yuan, Anil Sood, Shannon Westin, Karen H. Lu, Amir Jazaeri","doi":"10.1016/j.isci.2024.109801","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508122,"journal":{"name":"iScience","volume":"375 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phase 1b Study of Batiraxcept in Combination with Durvalumab in Patients with Platinum-Resistant Ovarian Cancer\",\"authors\":\"A. Knisely, Emily Hinchcliff, Elisabeth Gardiner, Reshma A. Rangwala, Kathryn Lito, B. Fellman, Ying Yuan, Anil Sood, Shannon Westin, Karen H. Lu, Amir Jazaeri\",\"doi\":\"10.1016/j.isci.2024.109801\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508122,\"journal\":{\"name\":\"iScience\",\"volume\":\"375 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"iScience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.isci.2024.109801\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"iScience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.isci.2024.109801","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}